Qi Biodesign Completes $75 Million in Total Funding to Drive Genome Editing Innovations
BEIJING, Dec. 6, 2024 /PRNewswire/ -- Qi Biodesign, a biotechnology company pioneering next-generation genome editing technologies, announced the completion of its Series A funding round. The company has now raised a total of $75 million across its...